Cargando…
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
The article gives an overview of current treatment options for metastatic hormone receptor-positive and HER2-negative breast cancer. The focus is on combined therapies, e.g., with CDK4/6 inhibition compared with purely endocrine-based therapies in the pre- and postmenopause, presenting the latest st...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Georg Thieme Verlag KG
2019
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924325/ https://www.ncbi.nlm.nih.gov/pubmed/31875862 http://dx.doi.org/10.1055/a-1037-5205 |